Bilirubin, a breakdown product of heme, is normally glucuronidated and excreted by the liver into bile. Failure of this system can lead to a buildup of conjugated bilirubin in the blood, resulting in jaundice. The mechanistic basis of bilirubin excretion and hyperbilirubinemia syndromes is largely understood, but that of Rotor syndrome, an autosomal recessive disorder characterized by conjugated hyperbilirubinemia, coproporphyrinuria, and near-absent hepatic uptake of anionic diagnostics, has remained enigmatic. Here, we analyzed 8 Rotor-syndrome families and found that Rotor syndrome was linked to mutations predicted to cause complete and simultaneous deficiencies of the organic anion transporting polypeptides OATP1B1 and OATP1B3. These important detoxification-limiting proteins mediate uptake and clearance of countless drugs and drug conjugates across the sinusoidal hepatocyte membrane. OATP1B1 polymorphisms have previously been linked to drug hypersensitivities. Using mice deficient in Oatp1a/1b and in the multispecific sinusoidal export pump Abcc3, we found that Abcc3 secretes bilirubin conjugates into the blood, while Oatp1a/1b transporters mediate their hepatic reuptake. Transgenic expression of human OATP1B1 or OATP1B3 restored the function of this detoxification-enhancing liver-blood shuttle in Oatp1a/1b-deficient mice. Within liver lobules, this shuttle may allow flexible transfer of bilirubin conjugates (and probably also drug conjugates) formed in upstream hepatocytes to downstream hepatocytes, thereby preventing local saturation of further detoxification processes and hepatocyte toxic injury. Thus, disruption of hepatic reuptake of bilirubin glucuronide due to coexisting OATP1B1 and OATP1B3 deficiencies explains Rotor-type hyperbilirubinemia. Moreover, OATP1B1 and OATP1B3 null mutations may confer substantial drug toxicity risks.
Evita van de Steeg, Viktor Stránecký, Hana Hartmannová, Lenka Nosková, Martin Hřebíček, Els Wagenaar, Anita van Esch, Dirk R. de Waart, Ronald P.J. Oude Elferink, Kathryn E. Kenworthy, Eva Sticová, Mohammad al-Edreesi, A.S. Knisely, Stanislav Kmoch, Milan Jirsa, Alfred H. Schinkel
Title and authors | Publication | Year |
---|---|---|
Drug‐Induced Liver Injury Associated With Emerging Cancer Therapies
Chodup P, Samodelov SL, Visentin M, Kullak\u2010Ublick GA |
Liver International | 2025 |
A lipid metabolism related gene signature predicts postoperative recurrence in pancreatic cancer through multicenter cohort validation
Deng Z, Yang Z, Li L, Zeng G, Meng Z, Liu R |
Scientific Reports | 2025 |
The Impact of Organic Anion-Transporting Polypeptide (OATP) Variants on the Side Effects of Direct-Acting Antivirals in Hepatitis C Patients
Altintas Z, Altintas E |
Cureus | 2025 |
SLCO1B1 Functional Variants, Bilirubin, Statin-Induced Myotoxicity, and Recent Sub-Saharan African Ancestry: A Precision Medicine Health Equity Study.
Haldar T, Kvale M, Yang J, Douglas MP, Coyote-Maetas W, Kachuri L, Witte JS, Iribarren C, Medina MW, Krauss RM, Yee SW, Oni-Orisan A |
Clinical pharmacology and therapeutics | 2025 |
Bilirubin – new insights into an old molecule
Čepelak I, Dodig S, Pavić I |
Biochemia Medica | 2025 |
Construction and characterization of a humanized SLCO1B1 rat model with its application in evaluating the uptake of different statins.
Zhang Y, Huang J, Huang S, Liu J, Deng L, Liang C, Guo Y, Yao B, Wang X |
Acta pharmaceutica Sinica. B | 2024 |
Pharmacokinetic Effects of Different Models of Nonalcoholic Fatty Liver Disease in Transgenic Humanized OATP1B Mice
Bechtold BJ, Lynch KD, Oyanna VO, Call MR, White LA, Graf TN, Oberlies NH, Clarke JD |
Drug Metabolism and Disposition | 2024 |
Rifampin- and Silymarin-mediated Pharmacokinetic Interactions of Exogenous and Endogenous Substrates in a Transgenic OATP1B Mouse Model
Bechtold BJ, Lynch KD, Oyanna VO, Call MR, Graf TN, Oberlies NH, Clarke JD |
Molecular Pharmaceutics | 2024 |
A pedigree analysis of Rotor hyperbilirubinemia combined with hepatitis B virus infection in a SLCO1B1 and SLCO1B3 gene mutations patient.
Lin LZ, Wu QY, Zhang JH, Li SJ, Wu WZ, Ruan DD, Wu M, Chen Q, Liao LS, Fang ZT, Luo JW, Li ZA, Li Z, Li H |
Heliyon | 2024 |
STING-mediated IL-6 Inhibits OATP1B1 Expression via the TCF4 Signaling Pathway in Cholestasis.
Guo Y, Zhang H, Zhao N, Peng Y, Shen D, Chen Y, Zhang X, Tang CE, Chai J |
Journal of Clinical and Translational Hepatology | 2024 |
Genome-wide analyses of neonatal jaundice reveal a marked departure from adult bilirubin metabolism
Solé-Navais P, Juodakis J, Ytterberg K, Wu X, Bradfield JP, Vaudel M, LaBella AL, Helgeland Ø, Flatley C, Geller F, Finel M, Zhao M, Lazarus P, Hakonarson H, Magnus P, Andreassen OA, Njølstad PR, Grant SF, Feenstra B, Muglia LJ, Johansson S, Zhang G, Jacobsson B |
Nature Communications | 2024 |
A Rare Case of Life-Threatening Jaundice Caused by Epstein-Barr Virus Infection and Secondary Cold Agglutinin Syndrome Successfully Treated with Rituximab.
Bellia M, Greco M, Lunghi M, Moia R, Gaidano G, Patriarca A |
International medical case reports journal | 2024 |
Effect of Organic Anion Transporting Polypeptide 1B1 on Plasma Concentration Dynamics of Clozapine in Patients with Treatment-Resistant Schizophrenia
Sato T, Kawabata T, Kumondai M, Hayashi N, Komatsu H, Kikuchi Y, Onoguchi G, Sato Y, Nanatani K, Hiratsuka M, Maekawa M, Yamaguchi H, Abe T, Tomita H, Mano N |
International Journal of Molecular Sciences | 2024 |
SLCO1B1 variants in a patient of African ancestry presenting with rosuvastatin‐induced rhabdomyolysis: A case report
Medwid S, Deckert R, Gryn SE, Kim RB |
British Journal of Clinical Pharmacology | 2024 |
Organic anion transporting polypeptide (OATP) 1B3 is a key transporter for hepatic uptake of conjugated bile acids in human liver
Qiong Pan, Jiafeng Ouyang, Ziqian Xu, Guanyu Zhu, Yao Tong, Nan Zhao, Xiaoxun Zhang, Ying Cheng, Liangjun Zhang, Ya Tan, Jianwei Li, Chengcheng Zhang, Wensheng Chen, Shi-Ying Cai, James Boyer, Jin Chai |
Cellular and Molecular Gastroenterology and Hepatology | 2023 |
Cellular Compartmentalization, Glutathione Transport and Its Relevance in Some Pathologies.
Vázquez-Meza H, Vilchis-Landeros MM, Vázquez-Carrada M, Uribe-Ramírez D, Matuz-Mares D |
2023 | |
Large-scale functional screen identifies genetic variants with splicing effects in modern and archaic humans
Rong S, Neil CR, Welch A, Duan C, Maguire S, Meremikwu IC, Meyerson M, Evans BJ, Fairbrother WG |
Proceedings of the National Academy of Sciences | 2023 |
Genetic alterations and molecular mechanisms underlying hereditary intrahepatic cholestasis.
Xie S, Wei S, Ma X, Wang R, He T, Zhang Z, Yang J, Wang J, Chang L, Jing M, Li H, Zhou X, Zhao Y |
Frontiers in pharmacology | 2023 |
Role of the Sodium-Dependent Organic Anion Transporter (SOAT/SLC10A6) in Physiology and Pathophysiology
Wannowius M, Karakus E, Aktürk Z, Breuer J, Geyer J |
International journal of molecular sciences | 2023 |
Cryo-EM structures of human organic anion transporting polypeptide OATP1B1.
Shan Z, Yang X, Liu H, Yuan Y, Xiao Y, Nan J, Zhang W, Song W, Wang J, Wei F, Zhang Y |
Cell Research | 2023 |
Development of a Pharmacokinetic Model That Accounts for the Plasma Concentrations of Conjugated and Unconjugated Bilirubin Observed in a Variety of Disease States
Levitt DG, Levitt MD |
Clinical and experimental gastroenterology | 2023 |
The Role of Uptake and Efflux Transporters in the Disposition of Glucuronide and Sulfate Conjugates
E Järvinen, F Deng, W Kiander, A Sinokki, H Kidron, N Sjöstedt |
Frontiers in pharmacology | 2022 |
The individual and global impact of copy-number variants on complex human traits
C Auwerx, M Lepamets, M Sadler, M Patxot, M Stojanov, D Baud, R Mägi, E Porcu, A Reymond, Z Kutalik, T Esko, A Metspalu, L Milani, R Mägi, M Nelis |
The American Journal of Human Genetics | 2022 |
The Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for SLCO1B1, ABCG2, and CYP2C9 and statin-associated musculoskeletal symptoms
Cooper-DeHoff RM, Niemi M, Ramsey LB, Luzum JA, Tarkiainen EK, Straka RJ, Gong L, Tuteja S, Wilke RA, Wadelius M, Larson EA, Roden DM, Klein TE, Yee SW, Krauss RM, Turner RM, Palaniappan L, Gaedigk A, Giacomini KM, Caudle KE, Voora D |
Clinical Pharmacology & Therapeutics | 2022 |
Associations between UGT1A1 and SLCO1B1 polymorphisms and susceptibility to neonatal hyperbilirubinemia in Thai population.
Atasilp C, Kanjanapipak J, Vichayaprasertkul J, Jinda P, Tiyasirichokchai R, Srisawasdi P, Prempunpong C, Chamnanphon M, Puangpetch A, Vanwong N, Klongthalay S, Jantararoungtong T, Sukasem C |
BMC Pediatrics | 2022 |
A study on setting standards for near-infrared fluorescence-image guided surgery (NIRFGS) time lapse monitoring based on preoperative liver function assessment.
Li Y, You Q, Wang Z, Cao Y, Butch CJ, Guissi NEI, Cai H, Wang Y, Lu Q |
Annals of translational medicine | 2022 |
Identification of Potential Insect Growth Inhibitor against Aedes aegypti: A Bioinformatics Approach.
Da Costa GV, Neto MFA, Da Silva AKP, De Sá EMF, Cancela LCF, Vega JS, Lobato CM, Zuliani JP, Espejo-Román JM, Campos JM, Leite FHA, Santos CBR |
International journal of molecular sciences | 2022 |
Influence of Tyrosine Kinase Inhibition on Organic Anion Transporting Polypeptide 1B3-Mediated Uptake.
Hove VN, Anderson K, Hayden ER, Pasquariello KZ, Gibson AA, Shen S, Qu J, Jin Y, Miecznikowski JC, Hu S, Sprowl JA |
Molecular pharmacology | 2022 |
Pharmacogenomics in Cytotoxic Chemotherapy of Cancer.
Talebi Z, Sparreboom A, Colace SI |
Methods in molecular biology (Clifton, N.J.) | 2022 |
A Metabolomics Approach for Predicting OATP1B-Type Transporter-Mediated Drug–Drug Interaction Liabilities
Li Y, Jin Y, Taheri H, Schmidt KT, Gibson AA, Buck SA, Eisenmann ED, Mathijssen RH, Figg WD, Baker SD, Sparreboom A, Hu S |
Pharmaceutics | 2022 |
Rotor Syndrome Presenting as Dubin-Johnson Syndrome.
Morais M, Couvert P, Jéru I, Machado MV |
Case reports in gastroenterology | 2022 |
iTRAQ Quantitative Proteomic Analysis of Different Expressed Proteins and Signal Pathways in Bakuchiol-Induced Hepatotoxicity
Gao SY, Xu DQ, Abulizi A, Maimaiti Y, Aibai S, Jiang ZZ, Zhang LY, Li ZJ |
Evidence-based complementary and alternative medicine : eCAM | 2022 |
Guarding the gate against hyperbilirubinaemia.
Zhang E, Huang W |
Gut | 2022 |
A historical review of jaundice: May the golden oriole live forever
Herta T, Beuers U |
Clinical Liver Disease | 2022 |
Identifying Novel Inhibitors for Hepatic Organic Anion Transporting Polypeptides by Machine Learning-Based Virtual Screening.
Tuerkova A, Bongers BJ, Norinder U, Ungvári O, Székely V, Tarnovskiy A, Szakács G, Özvegy-Laczka C, van Westen GJP, Zdrazil B |
Journal of Chemical Information and Modeling | 2022 |
Role of in vitro two-dimensional (2D) and three-dimensional (3D) cell culture systems for ADME-Tox screening in drug discovery and development: a comprehensive review
Chunduri V, Maddi S |
2022 | |
PharmVar GeneFocus: SLCO1B1.
Ramsey LB, Gong L, Lee SB, Wagner JB, Zhou X, Sangkuhl K, Adams SM, Straka RJ, Empey PE, Boone EC, Klein TE, Niemi M, Gaedigk A |
Clinical Pharmacology & Therapeutics | 2022 |
Endogenous Biomarkers for SLC Transporter-Mediated Drug-Drug Interaction Evaluation
Y Li, Z Talebi, X Chen, A Sparreboom, S Hu |
Molecules (Basel, Switzerland) | 2021 |
Enzyme Kinetics in Drug Metabolism: Fundamentals and Applications
S Nagar, UA Argikar, D Tweedie |
2021 | |
Organic Anion Transporting Polypeptide 2B1 (OATP2B1) Genetic Variants: In Vitro Functional Characterization and Association With Circulating Concentrations of Endogenous Substrates
S Medwid, HR Price, DP Taylor, J Mailloux, UI Schwarz, RB Kim, RG Tirona |
Frontiers in pharmacology | 2021 |
An EAV-HP insertion in the promoter region of SLCO1B3 has pleiotropic effects on chicken liver metabolism based on the transcriptome and proteome analysis
J Chen, G Hua, D Han, X Zheng, X Dong, S Wang, J Long, Z Zheng, A Wang, J Wang, X Wang, X Deng |
Scientific Reports | 2021 |
Multi-factorial pharmacokinetic interactions: unraveling complexities in precision drug therapy
B Bechtold, J Clarke |
Expert Opinion on Drug Metabolism & Toxicology | 2021 |
Application of a PBPK model to elucidate the changes of systemic and liver exposures for rosuvastatin, carotegrast, and bromfenac followed by OATP inhibition in monkeys
Y Cheng, X Liang, J Hao, C Niu, Y Lai |
Clinical and Translational Science | 2021 |
CRISPR-Cas9: A method for establishing rat models of drug metabolism and pharmacokinetics
Lu J, Liu J, Guo Y, Zhang Y, Xu Y, Wang X |
Acta pharmaceutica Sinica. B | 2021 |
The Genetics of Inherited Cholestatic Disorders in Neonates and Infants: Evolving Challenges
Jeyaraj R, Bounford KM, Ruth N, Lloyd C, MacDonald F, Hendriksz CJ, Baumann U, Gissen P, Kelly D |
Genes & development | 2021 |
Pediatric Cholestatic Liver Disease: Review of Bile Acid Metabolism and Discussion of Current and Emerging Therapies
A Kriegermeier, R Green |
Frontiers in Medicine | 2020 |
OATP1A/1B, CYP3A, ABCB1, and ABCG2 limit oral availability of the NTRK inhibitor larotrectinib, while ABCB1 and ABCG2 also restrict its brain accumulation
Y Wang, RW Sparidans, W Li, MC Lebre, JH Beijnen, AH Schinkel |
British Journal of Pharmacology | 2020 |
Characterization of organic anion transporting polypeptide 1b2 knockout rats generated by CRISPR/Cas9: a novel model for drug transport and hyperbilirubinemia disease
X Ma, X Shang, X Qin, J Lu, M Liu, X Wang |
Acta pharmaceutica Sinica. B | 2020 |
Uptake Transporters of the SLC21, SLC22A, and SLC15A Families in Anticancer Therapy—Modulators of Cellular Entry or Pharmacokinetics?
K Brecht, AM Schäfer, HE zu Schwabedissen |
Cancers | 2020 |
Role of Oatp2b1 in Drug Absorption and Drug-Drug Interactions
M Chen, S Hu, Y Li, AA Gibson, Q Fu, SD Baker, A Sparreboom |
Drug Metabolism and Disposition | 2020 |
Prediction of Drug-Induced Hyperbilirubinemia by In Vitro Testing
P Tátrai, P Krajcsi |
Pharmaceutics | 2020 |
Insertion of LINE-1 Retrotransposon Inducing Exon Inversion Causes a Rotor Syndrome Phenotype
D Zhou, S Qi, W Zhang, L Wu, A Xu, X Li, B Zhang, Y Li, S Jia, H Wang, J Jia, X Ou, J Huang, H You |
Frontiers in Genetics | 2020 |
Coproporphyrin I Can Serve as an Endogenous Biomarker for OATP1B1 Inhibition: Assessment Using a Glecaprevir/Pibrentasvir Clinical Study
HV Kalluri, R Kikuchi, S Coppola, J Schmidt, ME Mohamed, DA Bow, AH Salem |
Clinical and Translational Science | 2020 |
Adenomatous polyposis coli-binding protein end-binding 1 promotes hepatocellular carcinoma growth and metastasis
T Aiyama, T Orimo, H Yokoo, T Ohata, KC Hatanaka, Y Hatanaka, M Fukai, T Kamiyama, A Taketomi, JW Lee |
PloS one | 2020 |
Differences in the Hemolytic Behavior of Two Isomers in Ophiopogon japonicus In Vitro and In Vivo and Their Risk Warnings
HH Xu, ZH Jiang, YT Sun, LZ Qiu, LL Xu, XL Tang, ZC Ma, Y Gao, S Qin |
Oxidative Medicine & Cellular Longevity | 2020 |
Rotor Syndrome: Glucuronidated Bile Acidemia From Defective Reuptake by Hepatocytes
A Kimura, T Kagawa, H Takei, Y Maruo, H Sakugawa, T Sasaki, T Murai, N Naritaka, H Takikawa, H Nittono |
Hepatology Communications | 2020 |
The involvement of human organic anion transporting polypeptides (OATPs) in drug-herb/food interactions
Y Ali, T Shams, K Wang, Z Cheng, Y Li, W Shu, X Bao, L Zhu, M Murray, F Zhou |
Chinese medicine | 2020 |
Isolated Elevated Bilirubin
Shroff H, Maddur H |
Clinical Liver Disease | 2020 |
The first Turkish family with Rotor syndrome diagnosed at the molecular level
Gümüş E, Karaca M, Deveci U, Jirsa M |
2020 | |
Organic Anion Transporting Polypeptides: Emerging Roles in Cancer Pharmacology
RR Schulte, RH Ho |
Molecular pharmacology | 2019 |
Quantitative Kinetic Models from Intravital Microscopy: A Case Study Using Hepatic Transport
M Tavakoli, K Tsekouras, R Day, KW Dunn, S Pressé |
The Journal of Physical Chemistry B | 2019 |
Clinical Pharmacokinetics and Pharmacodynamics of Transarterial Chemoembolization and Targeted Therapies in Hepatocellular Carcinoma
A Hulin, J Stocco, M Bouattour |
Clinical Pharmacokinetics | 2019 |
Interaction Between Sex and Organic Anion‐Transporting Polypeptide 1b2 on the Pharmacokinetics of Regorafenib and Its Metabolites Regorafenib‐N‐Oxide and Regorafenib‐Glucuronide in Mice
Q Fu, M Chen, JT Anderson, X Sun, S Hu, A Sparreboom, SD Baker |
Clinical and Translational Science | 2019 |
Protein-protein interactions of drug uptake transporters that are important for liver and kidney
Y Zhang, B Hagenbuch |
Biochemical Pharmacology | 2019 |
Next generation sequencing reveals co-existence of hereditary spherocytosis and Dubin–Johnson syndrome in a Chinese gril: A case report
Y Li, Y Li, Y Yang, WR Yang, JP Li, GX Peng, L Song, HH Fan, L Ye, YZ Xiong, ZJ Wu, K Zhou, X Zhao, LP Jing, FK Zhang, L Zhang |
World journal of clinical cases | 2019 |
Combined Effects of UGT1A1 and SLCO1B1 Variants on Chinese Adult Mild Unconjugated Hyperbilirubinemia
J Bai, L Luo, S Liu, C Liang, L Bai, Y Chen, S Zheng, Z Duan |
Frontiers in Genetics | 2019 |
The Emerging Role of the SLCO1B3 Protein in Cancer Resistance
R Sun, Y Ying, Z Tang, T Liu, F Shi, H Li, T Guo, S Huang, R Lai |
Protein and peptide letters | 2019 |
Influence of Uridine Diphosphate Glucuronosyltransferase Family 1 Member A1 and Solute Carrier Organic Anion Transporter Family 1 Member B1 Polymorphisms and Efavirenz on Bilirubin Disposition in Healthy Volunteers
KS Collins, IF Metzger, BT Gufford, JB Lu, EB Medeiros, VM Pratt, TC Skaar, Z Desta |
Drug Metabolism and Disposition | 2019 |
Animal models to study bile acid metabolism
J Li, PA Dawson |
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease | 2018 |
Bilirubin in the Liver–Gut Signaling Axis
AR Hamoud, L Weaver, DE Stec, TD Hinds |
Trends in endocrinology and metabolism: TEM | 2018 |
Regulation of Organic Anion Transporting Polypeptides (OATP) 1B1- and OATP1B3-Mediated Transport: An Updated Review in the Context of OATP-Mediated Drug-Drug Interactions
K Alam, A Crowe, X Wang, P Zhang, K Ding, L Li, W Yue |
International journal of molecular sciences | 2018 |
Identification of novel cell-impermeant fluorescent substrates for testing the function and drug interaction of Organic Anion-Transporting Polypeptides, OATP1B1/1B3 and 2B1
I Patik, V Székely, O Német, Á Szepesi, N Kucsma, G Várady, G Szakács, É Bakos, C Özvegy-Laczka |
Scientific Reports | 2018 |
Evaluation of Drug Biliary Excretion Using Sandwich-Cultured Human Hepatocytes
O Fardel, A Moreau, ML Vée, C Denizot, Y Parmentier |
European Journal of Drug Metabolism and Pharmacokinetics | 2018 |
Jaundice revisited: recent advances in the diagnosis and treatment of inherited cholestatic liver diseases
HL Chen, SH Wu, SH Hsu, BY Liou, HL Chen, MH Chang |
Journal of Biomedical Science | 2018 |
Quantitative Prediction of OATP‐Mediated Drug‐Drug Interactions With Model‐Based Analysis of Endogenous Biomarker Kinetics
Yoshida K, Guo C, Sane R |
The Journal of Pathology | 2018 |
Variants Associated with Infantile Cholestatic Syndromes Detected in Extrahepatic Biliary Atresia by Whole Exome Studies: A 20-Case Series from Thailand
Sangkhathat S, Laochareonsuk W, Maneechay W, Kayasut K, Chiengkriwate P |
Journal of pediatric genetics | 2018 |
Bile Acid Uptake Transporters as Targets for Therapy
D Slijepcevic, SF van de Graaf |
Digestive Diseases | 2017 |
Hepatic uptake of conjugated bile acids is mediated by both sodium taurocholate cotransporting polypeptide and organic anion transporting polypeptides and modulated by intestinal sensing of plasma bile acid levels in mice
D Slijepcevic, RL Abbing, T Katafuchi, A Blank, JM Donkers, S Hoppe, DR de Waart, D Tolenaars, JH van der Meer, M Wildenberg, U Beuers, RP Elferink, AH Schinkel, SF van de Graaf |
Hepatology | 2017 |
Membrane Transporters for Bilirubin and Its Conjugates: A Systematic Review
J Čvorović, S Passamonti |
Frontiers in pharmacology | 2017 |
Glucuronidation: driving factors and their impact on glucuronide disposition
G Yang, S Ge, R Singh, S Basu, K Shatzer, M Zen, J Liu, Y Tu, C Zhang, J Wei, J Shi, L Zhu, Z Liu, Y Wang, S Gao, M Hu |
Drug Metabolism Reviews | 2017 |
2016 Presidential Address: Let’s Make Human Genetics Great (Again): The Importance of Beauty in Science 1
HC Dietz |
The American Journal of Human Genetics | 2017 |
Systems pharmacology modeling of drug-induced hyperbilirubinemia: Differentiating hepatotoxicity and inhibition of enzymes/transporters
K Yang, C Battista, JL Woodhead, SH Stahl, JT Mettetal, PB Watkins, SQ Siler, BA Howell |
Clinical Pharmacology & Therapeutics | 2017 |
Interindividual and interethnic variability in drug disposition: polymorphisms in organic anion transporting polypeptide 1B1 (OATP1B1; SLCO1B1).
Lee HH, Ho RH |
British Journal of Clinical Pharmacology | 2017 |
eUnaG: a new ligand-inducible fluorescent reporter to detect drug transporter activity in live cells.
Yeh JT, Nam K, Yeh JT, Perrimon N |
Scientific Reports | 2017 |
Loss of organic anion transporting polypeptide 1B3 function causes marked delay in indocyanine green clearance without any clinical symptoms.
Kagawa T, Adachi Y, Hashimoto N, Mitsui H, Ohashi T, Yoneda M, Hasegawa I, Hirose S, Tsuruya K, Anzai K, Mine T |
Hepatology | 2017 |
ATP11C targets basolateral bile salt transporter proteins in mouse central hepatocytes: de Waart, Naik et al
DR de Waart, J Naik, KS Utsunomiya, S Duijst, K Ho-Mok, AR Bolier, J Hiralall, LN Bull, PJ Bosma, RP Elferink, CC Paulusma |
Hepatology | 2016 |
Sandwich-Cultured Hepatocytes as a Tool to Study Drug Disposition and Drug-Induced Liver Injury
K Yang, C Guo, JL Woodhead, RL st. Claire, PB Watkins, SQ Siler, BA Howell, KL Brouwer |
Journal of Pharmaceutical Sciences | 2016 |
Autosomal-Dominant Corneal Endothelial Dystrophies CHED1 and PPCD1 Are Allelic Disorders Caused by Non-coding Mutations in the Promoter of OVOL2
AE Davidson, P Liskova, CJ Evans, L Dudakova, L Nosková, N Pontikos, H Hartmannová, K Hodaňová, V Stránecký, Z Kozmík, HJ Levis, N Idigo, N Sasai, GJ Maher, J Bellingham, N Veli, ND Ebenezer, ME Cheetham, JT Daniels, CM Thaung, K Jirsova, V Plagnol, M Filipec, S Kmoch, SJ Tuft, AJ Hardcastle |
The American Journal of Human Genetics | 2016 |
Expression Patterns of Organic Anion Transporting Polypeptides 1B1 and 1B3 Protein in Human Pediatric Liver
MM Thomson, RN Hines, EG Schuetz, B Meibohm |
Drug metabolism and disposition: the biological fate of chemicals | 2016 |
Central bisectionectomy for hepatocellular carcinoma in a patient with indocyanine green excretory defect associated with reduced expression of the liver transporter
S Imada, T Kobayashi, A Kitao, O Matsui, M Hashimoto, K Ide, K Ishiyama, K Arihiro, H Tashiro, H Ohdan |
Surgical Case Reports | 2016 |
Hepatocellular Shuttling and Recirculation of Sorafenib-Glucuronide Is Dependent on Abcc2, Abcc3, and Oatp1a/1b
A Vasilyeva, S Durmus, L Li, E Wagenaar, S Hu, AA Gibson, JC Panetta, S Mani, A Sparreboom, SD Baker, AH Schinkel |
Cancer research | 2015 |
SLC transporters as therapeutic targets: emerging opportunities
L Lin, SW Yee, RB Kim, KM Giacomini |
Nature Reviews Drug Discovery | 2015 |
Neonatal Cholestasis – Differential Diagnoses, Current Diagnostic Procedures, and Treatment
T Götze, H Blessing, C Grillhösl, P Gerner, Aà Hoerning |
Frontiers in Pediatrics | 2015 |
Genetic and biochemical study of dual hereditary jaundice: Dubin–Johnson and Gilbert’s syndromes. Haplotyping and founder effect of deletion in ABCC2
L Slachtova, O Seda, J Behunova, M Mistrik, P Martasek |
European Journal of Human Genetics | 2015 |
Structural and Functional Hepatocyte Polarity and Liver Disease
P Gissen, IM Arias |
Journal of Hepatology | 2015 |
Inherited disorders of bilirubin clearance
N Memon, BI Weinberger, T Hegyi, LM Aleksunes |
Pediatric Research | 2015 |
Gene Replacement Therapy for Genetic Hepatocellular Jaundice
R van Dijk, U Beuers, PJ Bosma |
Clinical Reviews in Allergy & Immunology | 2014 |
Quantitative assessment of the multiple processes responsible for bilirubin homeostasis in health and disease
D Levitt, M Levitt |
Clinical and experimental gastroenterology | 2014 |
Comprehensive Physiology
AW Wolkoff |
Comprehensive Physiology | 2014 |
Association of neonatal hyperbilirubinemia in breast-fed infants with UGT1A1 or SLCOs polymorphisms
H Sato, T Uchida, K Toyota, T Nakamura, G Tamiya, M Kanno, T Hashimoto, M Watanabe, K Aoki, K Hayasaka |
Journal of Human Genetics | 2014 |
Development and Characterization of a Novel Mouse Line Humanized for the Intestinal Peptide Transporter PEPT1
Y Hu, Y Xie, Y Wang, X Chen, DE Smith |
Molecular Pharmaceutics | 2014 |
The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin-Induced Myopathy: 2014 Update
LB Ramsey, SG Johnson, KE Caudle, CE Haidar, D Voora, RA Wilke, WD Maxwell, HL McLeod, RM Krauss, DM Roden, Q Feng, RM Cooper-DeHoff, L Gong, TE Klein, M Wadelius, M Niemi |
Clinical Pharmacology & Therapeutics | 2014 |
Substantial Effect of Efavirenz Monotherapy on Bilirubin Levels in Healthy Volunteers
IF Metzger, TC Quigg, N Epstein, AO Aregbe, N Thong, JT Callaghan, DA Flockhart, AT Nguyen, CK Stevens, SK Gupta, Z Desta |
Current Therapeutic Research | 2014 |
Not all (bile acids) who wander are lost: The first report of a patient with an isolated NTCP defect
SJ Karpen, PA Dawson |
Hepatology | 2014 |
Different Interaction Profiles of Direct-Acting Anti-Hepatitis C Virus Agents with Human Organic Anion Transporting Polypeptides
T Furihata, S Matsumoto, Z Fu, A Tsubota, Y Sun, S Matsumoto, K Kobayashi, K Chiba |
Antimicrobial agents and chemotherapy | 2014 |
Comprehensive Physiology
BJ Wilkins, M Pack |
Comprehensive Physiology | 2013 |
Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME
P Godoy, NJ Hewitt, U Albrecht, ME Andersen, N Ansari, S Bhattacharya, JG Bode, J Bolleyn, C Borner, J Böttger, A Braeuning, RA Budinsky, B Burkhardt, NR Cameron, G Camussi, CS Cho, YJ Choi, JC Rowlands, U Dahmen, G Damm, O Dirsch, MT Donato, J Dong, S Dooley, D Drasdo, R Eakins, KS Ferreira, V Fonsato, J Fraczek, R Gebhardt, A Gibson, M Glanemann, CE Goldring, MJ Gómez-Lechón, GM Groothuis, L Gustavsson, C Guyot, D Hallifax, S Hammad, A Hayward, D Häussinger, C Hellerbrand, P Hewitt, S Hoehme, HG Holzhütter, JB Houston, J Hrach, K Ito, H Jaeschke, V Keitel, JM Kelm, BK Park, C Kordes, GA Kullak-Ublick, EL LeCluyse, P Lu, J Luebke-Wheeler, A Lutz, DJ Maltman, M Matz-Soja, P McMullen, I Merfort, S Messner, C Meyer, J Mwinyi, DJ Naisbitt, AK Nussler, P Olinga, F Pampaloni, J Pi, L Pluta, SA Przyborski, A Ramachandran, V Rogiers, C Rowe, C Schelcher, K Schmich, M Schwarz, B Singh, EH Stelzer, B Stieger, R Stöber, Y Sugiyama, C Tetta, WE Thasler, T Vanhaecke, M Vinken, TS Weiss, A Widera, CG Woods, JJ Xu, KM Yarborough, JG Hengstler |
Archives of Toxicology | 2013 |
Nuclear-receptor–mediated regulation of drug– and bile-acid–transporter proteins in gut and liver
JL Staudinger, S Woody, M Sun, W Cui |
Drug Metabolism Reviews | 2013 |
Digenic inheritance in medical genetics
AA Schaffer |
Journal of medical genetics | 2013 |
New insights in bilirubin metabolism and their clinical implications
E Sticova, M Jirsa |
World journal of gastroenterology : WJG | 2013 |
Contribution of OATP1B1 and OATP1B3 to the disposition of sorafenib and sorafenib-glucuronide
EI Zimmerman, S Hu, JL Roberts, AA Gibson, SJ Orwick, L Li, A Sparreboom, SD Baker |
Clinical cancer research | 2013 |
Organic anion transporting polypeptide 1B transporters modulate hydroxyurea pharmacokinetics
AL Walker, CS Lancaster, D Finkelstein, RE Ware, A Sparreboom |
American journal of physiology. Cell physiology | 2013 |
Utility of Oatp1a/1b-Knockout and OATP1B1/3-Humanized Mice in the Study of OATP-Mediated Pharmacokinetics and Tissue Distribution: Case Studies with Pravastatin, Atorvastatin, Simvastatin, and Carboxydichlorofluorescein
JW Higgins, JQ Bao, AB Ke, JR Manro, JK Fallon, PC Smith, MJ Zamek-Gliszczynski |
Drug Metabolism and Disposition | 2013 |
Genetics is a major determinant of expression of the human hepatic uptake transporter OATP1B1, but not of OATP1B3 and OATP2B1
AT Nies, M Niemi, O Burk, S Winter, UM Zanger, B Stieger, M Schwab, E Schaeffeler |
Genome Medicine | 2013 |
ITC Recommendations for Transporter Kinetic Parameter Estimation and Translational Modeling of Transport-Mediated PK and DDIs in Humans
MJ Zamek-Gliszczynski, CA Lee, A Poirier, J Bentz, X Chu, H Ellens, T Ishikawa, M Jamei, JC Kalvass, S Nagar, KS Pang, K Korzekwa, PW Swaan, ME Taub, P Zhao, A Galetin |
Clinical Pharmacology & Therapeutics | 2013 |
Mutations in ANTXR1 Cause GAPO Syndrome
V Stránecký, A Hoischen, H Hartmannová, MS Zaki, A Chaudhary, E Zudaire, L Nosková, V Barešová, A Přistoupilová, K Hodaňová, J Sovová, H Hůlková, L Piherová, JY Hehir-Kwa, D de Silva, MP Senanayake, S Farrag, J Zeman, P Martásek, A Baxová, HH Afifi, B St. Croix, HG Brunner, S Temtamy, S Kmoch |
The American Journal of Human Genetics | 2013 |
Glutathione transferase-A2 S112T polymorphism predicts survival, transplant-related mortality, busulfan and bilirubin blood levels after allogeneic stem cell transplantation
F Bonifazi, G Storci, G Bandini, E Marasco, E Dan, E Zani, F Albani, S Bertoni, A Bontadini, SD Carolis, MR Sapienza, S Rizzi, MR Motta, M Ferioli, P Garagnani, M Cavo, V Mantovani, M Bonafe |
2013 | |
Uptake Carriers and Oncology Drug Safety
JA Sprowl, A Sparreboom |
Drug metabolism and disposition: the biological fate of chemicals | 2013 |
Epigenetic regulation of organic anion transporting polypeptide 1B3 in cancer cell lines.
Imai S, Kikuchi R, Tsuruya Y, Naoi S, Nishida S, Kusuhara H, Sugiyama Y |
Pharmaceutical Research | 2013 |
Influence of Polymorphic OATP1B-Type Carriers on the Disposition of Docetaxel
AJ de Graan, CS Lancaster, A Obaidat, B Hagenbuch, L Elens, LE Friberg, P de Bruijn, S Hu, AA Gibson, GH Bruun, TJ Corydon, TS Mikkelsen, AL Walker, G Du, WJ Loos, RH van Schaik, SD Baker, RH Mathijssen, A Sparreboom |
Clinical cancer research | 2012 |
The SLCO (former SLC21) superfamily of transporters
B Hagenbuch, B Stieger |
Molecular Aspects of Medicine | 2012 |
OATP1B1 Polymorphism as a Determinant of Erythromycin Disposition
CS Lancaster, GH Bruun, CJ Peer, TS Mikkelsen, TJ Corydon, AA Gibson, S Hu, SJ Orwick, RH Mathijssen, WD Figg, SD Baker, A Sparreboom |
Clinical Pharmacology & Therapeutics | 2012 |
Loss of OATP1B3 function causes Rotor syndrome: Implications for potential use of inhibitors in cancer
E Pratt, TM Sissung, WD Figg |
Cancer biology & therapy | 2012 |
The clinical pharmacogenomics implementation consortium: CPIC guideline for SLCO1B1 and simvastatin-induced myopathy.
Wilke RA, Ramsey LB, Johnson SG, Maxwell WD, McLeod HL, Voora D, Krauss RM, Roden DM, Feng Q, Cooper-Dehoff RM, Gong L, Klein TE, Wadelius M, Niemi M |
Clinical Pharmacology & Therapeutics | 2012 |
Contribution of the OATP1B subfamily to cancer biology and treatment.
Sissung TM, Reece KM, Spencer S, Figg WD |
Clinical Pharmacology & Therapeutics | 2012 |
Current challenges and controversies in drug-induced liver injury.
Corsini A, Ganey P, Ju C, Kaplowitz N, Pessayre D, Roth R, Watkins PB, Albassam M, Liu B, Stancic S, Suter L, Bortolini M |
Drug Safety | 2012 |
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |